What is Dendritic Cell Therapy for Cancer?
What are Dendritic Cells?
Dendritic cells (DCs) are specialized immune cells known as antigen-presenting cells that serve as crucial coordinators of the immune system. These remarkable cells act as key regulators capable of activating T-cells and stimulating the growth and differentiation of B-cells. What makes dendritic cells unique is their ability to identify specific protein markers, called peptides, on the surface of foreign or invading cells.
Once dendritic cells detect these peptide markers, they present them to other immune system cells, essentially teaching them to recognize and target cells that carry these specific markers. This process enables the immune system to seek out and destroy unwanted cells, including cancer cells.
Dendritic Cell Therapy
Dendritic cell therapy is an innovative autologous cancer treatment approach that harnesses the natural action of dendritic cells to combat cancer. This therapy works by identifying specific antigens on cancer cells circulating in an individual's blood, enabling the immune system to recognize and destroy these cancer cells throughout the body.
What sets dendritic cell therapy apart from traditional cancer treatments is its personalized approach and gentle mechanism of action. Unlike chemotherapy, dendritic cell therapy is not a genetic therapy and does not involve the use of genotoxic (chemotherapy) drugs. Instead, it works with the body's existing immune system to create a targeted response against cancer cells.
One of the most significant advantages of dendritic cells and cancer therapy is its ability to stimulate memory cells, providing long-lasting immunity against cancer. This means that if the therapy is successful, patients may have ongoing protection against cancer recurrence.
